Risk factor
Very poor trading liquidity
Profitability factor
Strong margins and returns
About
AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of AFT.NZ is 3.9 and suggests 11% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell